Stocks
Halozyme (HALO) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 259.0 | 315.5 | 451.9 | 656.5 | 573.1 | 960.6 | ||
| Changes by years, y/y, % | +69% | +22% | +43% | +45% | -13% | +30.2% | |||
Halozyme. EBITDA US GAAP, bln rub
Halozyme. EBITDA US GAAP, changes, %
Halozyme. EBITDA US GAAP, sum by quarters, bln rub
Halozyme (HALO) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | 162.0 | 229.8 | 243.7 | -69.3 | 219.6 | 960.6 | |
| Changes by years, y/y, % | +40% | +67% | +28% | -134% | +36% | |||
| Changes by quarters, q/q, % | -20% | +42% | +6% | -128% | -417% | |||
